249
Views
17
CrossRef citations to date
0
Altmetric
Clinical Features

Clopidogrel, Prasugrel, or Ticagrelor? A Practical Guide to Use of Antiplatelet Agents in Patients With Acute Coronary Syndromes

, PharmD & , PharmD
Pages 91-102 | Published online: 13 Mar 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Nawal Farhat, Yannick Fortin, Nisrine Haddad, Nicholas Birkett, Donald R. Mattison, Franco Momoli, Shi Wu Wen & Daniel Krewski. (2019) Systematic review and meta-analysis of adverse cardiovascular events associated with proton pump inhibitors used alone or in combination with antiplatelet agents. Critical Reviews in Toxicology 49:3, pages 215-261.
Read now

Articles from other publishers (16)

Vivien Hohberg, Jan-Niklas Kreppke, Jan Kohl, Eleonora Seelig, Lukas Zahner, Fiona Streckmann, Markus Gerber, Daniel König & Oliver Faude. (2022) Effectiveness of a personal health coaching intervention (diabetescoach) in patients with type 2 diabetes: protocol for an open-label, pragmatic randomised controlled trial. BMJ Open 12:6, pages e057948.
Crossref
Kamlesh K. Lodha, Deepak S. Wavhal, Sujit B. Bhalekar, Rohan J. Meshram & Vaishali S. Shinde. (2022) Exploring New Tetrahydrothienopyridine Derivatives as Platelet Agglutination Inhibitors: Synthesis, Biological Evaluation and In Silico Study. ChemistrySelect 7:2.
Crossref
Edidiong Orok, Funmilayo Adeniyi & Oluwole Akawa. 2022. Atrial Fibrillation - Diagnosis and Management in the 21st Century [Working Title]. Atrial Fibrillation - Diagnosis and Management in the 21st Century [Working Title].
L.M. Camargo, P.C.T.M. Lima, K. Janot & I.L. Maldonado. (2021) Safety of Oral P2Y12 Inhibitors in Interventional Neuroradiology: Current Status and Perspectives. American Journal of Neuroradiology 42:12, pages 2119-2126.
Crossref
Selvakumar Muruganantham, Venkateshwaran Krishnaswami, Shanmugarathinam Alagarsamy & Ruckmani Kandasamy. (2021) Anti-platelet Drug-loaded Targeted Technologies for the Effective Treatment of Atherothrombosis. Current Drug Targets 22:4, pages 399-419.
Crossref
Yonggu Lee, Young-Hyo Lim, Yongwhi Park & Jinho Shin. (2020) Real-World Bleeding and Ischemic Events in Asian Patients on P2Y12-Inhibitors After Percutaneous Coronary Intervention: A National Claims Data Analysis. Advances in Therapy 38:1, pages 562-578.
Crossref
Bhawani Yasassri Alvitigala, Lallindra Viranjan Gooneratne, Godwin Roger Constantine, Rajapaksha Arachchige Namal Kumaras Wijesinghe & Liyanage Dona Ashanthi Menuka Arawwawala. (2020) Pharmacokinetic, pharmacodynamic, and pharmacogenetic assays to monitor clopidogrel therapy. Pharmacology Research & Perspectives 8:6.
Crossref
Kyung-In Joung, Kwang Hyun Kim, Cheng-Yang Hsieh & Ju-Young Shin. (2020) Exploring pharmacogenetic difference using adverse event database: an example of clopidogrel and cardiovascular events. Pharmacogenomics 21:16, pages 1157-1168.
Crossref
Michael Spartalis, Eleni Tzatzaki, Eleftherios Spartalis, Stavroula A Paschou, Antonios Athanasiou, Dimitrios C Iliopoulos, Gerasimos Siasos & Vassilis Voudris. (2020) Prasugrel in the treatment of acute coronary syndrome. Future Cardiology 16:6, pages 559-568.
Crossref
Jean Terrier, Youssef Daali, Pierre Fontana, Chantal Csajka & Jean-Luc Reny. (2019) Towards Personalized Antithrombotic Treatments: Focus on P2Y12 Inhibitors and Direct Oral Anticoagulants. Clinical Pharmacokinetics 58:12, pages 1517-1532.
Crossref
Soo-In Chae, Hee Jo Yoo, Su-Yeon Lee, Eun Kyoung Chung, Wang-Seob Shim & Kyung-Tae Lee. (2019) Development and Validation of Simple LC–MS-MS Assay for the Quantitative Determination of Ticagrelor in Human Plasma: its Application to a Bioequivalence Study. Journal of Chromatographic Science 57:4, pages 331-338.
Crossref
Gianfanco Calogiuri, Alessandro Mandurino-Mirizzi, Claudio Parlangeli, Luigi Macchia, Caterina Foti & Michael P. Savage. (2019) Comparing Allergist and Cardiologist Considerations for the Optimal Management of Thienopyridines Hypersensitivity. Endocrine, Metabolic & Immune Disorders - Drug Targets 19:1, pages 2-12.
Crossref
Csaba András Dézsi, Balázs Bence Dézsi & Döme András Dézsi. (2018) Triple therapy with dual antiplatelet treatment and direct oral anticoagulants. Author's reply. European Journal of Internal Medicine 47, pages e21-e22.
Crossref
Mrudula Kudaravalli, Andrew D. Althouse, Oscar C. Marroquin, Sameer J. Khandhar, Michael S. Sharbaugh, Catalin Toma, A.J. Conrad Smith, John T. Schindler, Joon S. Lee & Suresh R. Mulukutla. (2016) Assessment of P2Y12 inhibitor usage and switching in acute coronary syndrome patients undergoing percutaneous coronary revascularization. International Journal of Cardiology 223, pages 854-859.
Crossref
Abdullah Pandor, Daniel Pollard, Tim Chico, Robert Henderson & Matt Stevenson. (2015) Rivaroxaban for Preventing Atherothrombotic Events in People with Acute Coronary Syndrome and Elevated Cardiac Biomarkers: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics 34:5, pages 463-477.
Crossref
Peter Chai & Kavita Babu. (2014) Toxin-induced Coagulopathy. Emergency Medicine Clinics of North America 32:1, pages 53-78.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.